Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: The last decade has seen the increasing use of biological medicines in combination with chemotherapy containing 5-fluorouracil/oxaliplatin or irinotecan for the treatment of metastatic colorectal cancer (mCRC). These combinations have resulted in increased progression-free survival (PFS)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BioDrugs
Main Authors: da Silva, Wânia Cristina, de Araujo, Vânia Eloisa, Lima, Ellias Magalhães e Abreu, dos Santos, Jessica Barreto Ribeiro, Silva, Michael Ruberson Ribeiro da, Almeida, Paulo Henrique Ribeiro Fernandes, de Assis Acurcio, Francisco, Godman, Brian, Kurdi, Amanj, Cherchiglia, Mariângela Leal, Andrade, Eli Iola Gurgel
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2018
Assuntos:
Systematic Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6290722/
https://ncbi.nlm.nih.gov/pubmed/30499082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-018-0322-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares